PL1751105T3 - Piperazynowe pochodne alkilooksyindoli - Google Patents

Piperazynowe pochodne alkilooksyindoli

Info

Publication number
PL1751105T3
PL1751105T3 PL05745440T PL05745440T PL1751105T3 PL 1751105 T3 PL1751105 T3 PL 1751105T3 PL 05745440 T PL05745440 T PL 05745440T PL 05745440 T PL05745440 T PL 05745440T PL 1751105 T3 PL1751105 T3 PL 1751105T3
Authority
PL
Poland
Prior art keywords
piperazine derivatives
oxindoles
alkyl
alkyl oxindoles
derivatives
Prior art date
Application number
PL05745440T
Other languages
English (en)
Inventor
Balázs Volk
József Barkóczy
Gyula Simig
Tibor Mezei
Dezsofi Rita Kapillerné
István Gacsályi
Katalin Pallagi
Gábor Gigler
György Lévay
Krisztina Móricz
Csilla Leveleki
Nóra Sziray
Gábor Szénási
András Egyed
László Gábor Hársing
Original Assignee
Egis Gyogyszergyar Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyrt filed Critical Egis Gyogyszergyar Nyrt
Publication of PL1751105T3 publication Critical patent/PL1751105T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
PL05745440T 2004-05-11 2005-05-11 Piperazynowe pochodne alkilooksyindoli PL1751105T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0400953A HUP0400953A3 (en) 2004-05-11 2004-05-11 Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
EP05745440A EP1751105B1 (en) 2004-05-11 2005-05-11 Piperazine derivatives of alkyl oxindoles
PCT/HU2005/000050 WO2005108364A1 (en) 2004-05-11 2005-05-11 Piperazine derivatives of alkyl oxindoles

Publications (1)

Publication Number Publication Date
PL1751105T3 true PL1751105T3 (pl) 2009-07-31

Family

ID=89982207

Family Applications (2)

Application Number Title Priority Date Filing Date
PL381615A PL381615A1 (pl) 2004-05-11 2005-05-11 Piperazynowe pochodne alkilooksyndoli
PL05745440T PL1751105T3 (pl) 2004-05-11 2005-05-11 Piperazynowe pochodne alkilooksyindoli

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL381615A PL381615A1 (pl) 2004-05-11 2005-05-11 Piperazynowe pochodne alkilooksyndoli

Country Status (27)

Country Link
US (1) US7910591B2 (pl)
EP (1) EP1751105B1 (pl)
JP (1) JP2007537227A (pl)
CN (1) CN101010296B (pl)
AT (1) ATE412633T1 (pl)
AU (1) AU2005240843B2 (pl)
BG (1) BG109769A (pl)
CA (1) CA2566096A1 (pl)
CZ (1) CZ2006779A3 (pl)
DE (1) DE602005010693D1 (pl)
DK (1) DK1751105T3 (pl)
EA (1) EA010789B1 (pl)
ES (1) ES2319795T3 (pl)
HR (1) HRP20060420A2 (pl)
HU (1) HUP0400953A3 (pl)
IL (1) IL179028A (pl)
MX (1) MXPA06013068A (pl)
NO (1) NO20065609L (pl)
NZ (1) NZ551545A (pl)
PL (2) PL381615A1 (pl)
PT (1) PT1751105E (pl)
RS (1) RS20060621A (pl)
SI (1) SI1751105T1 (pl)
SK (1) SK51102006A3 (pl)
UA (1) UA84927C2 (pl)
WO (1) WO2005108364A1 (pl)
ZA (1) ZA200610345B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
CN104163813B (zh) * 2013-05-16 2017-02-01 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
CN106243088B (zh) 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
WO1998008816A1 (fr) * 1996-08-26 1998-03-05 Meiji Seika Kaisha, Ltd. Derives d'indoxyle et psychotropes
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use

Also Published As

Publication number Publication date
SK51102006A3 (sk) 2007-05-03
WO2005108364A1 (en) 2005-11-17
EP1751105B1 (en) 2008-10-29
DE602005010693D1 (de) 2008-12-11
DK1751105T3 (da) 2009-03-09
IL179028A (en) 2011-08-31
JP2007537227A (ja) 2007-12-20
AU2005240843B2 (en) 2012-02-02
CN101010296B (zh) 2011-08-17
UA84927C2 (en) 2008-12-10
HU0400953D0 (en) 2004-07-28
US7910591B2 (en) 2011-03-22
MXPA06013068A (es) 2007-05-04
SI1751105T1 (sl) 2009-06-30
HUP0400953A2 (en) 2007-09-28
ATE412633T1 (de) 2008-11-15
CZ2006779A3 (cs) 2007-03-07
EP1751105A1 (en) 2007-02-14
NO20065609L (no) 2007-02-05
PT1751105E (pt) 2009-02-10
AU2005240843A1 (en) 2005-11-17
RS20060621A (en) 2008-09-29
HRP20060420A2 (en) 2007-04-30
CN101010296A (zh) 2007-08-01
CA2566096A1 (en) 2005-11-17
NZ551545A (en) 2010-07-30
BG109769A (bg) 2008-03-31
PL381615A1 (pl) 2007-06-11
US20080161323A1 (en) 2008-07-03
ZA200610345B (en) 2008-05-28
EA200602084A1 (ru) 2007-04-27
IL179028A0 (en) 2007-03-08
HUP0400953A3 (en) 2008-02-28
ES2319795T3 (es) 2009-05-12
EA010789B1 (ru) 2008-10-30

Similar Documents

Publication Publication Date Title
TW200736233A (en) Cyclohexyl piperazinyl methanone derivatives
GEP20084550B (en) Substituted morpholine compounds for the treatment of central nervous system disorders
HK1098047A1 (en) Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
TW200716118A (en) Aminopyrimidines as kinase modulators
IL176111A0 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
TW200718693A (en) Aminopyrimidines as kinase modulators
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
MX2007004910A (es) Nuevos derivados de indol o benzimidazol.
MX2008002158A (es) Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6.
IL179028A0 (en) Piperazine derivatives of alkyl oxindoles
UA94054C2 (en) Nitrocatechol derivatives as comt inhibitors
TW200621711A (en) 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I ε
RS20060619A (sr) Piridinski derivati alkil oksindola kao aktivna sredstva koja deluju na 5-ht7 receptor
EP1978959A4 (en) PIPERIDINE AND PIPERAZINE DERIVATIVES
EP1988902A4 (en) PIPERAZIN DERIVATIVES
IL178759A0 (en) Piperazine derivatives of alkyl oxindoles
RS20050421A (en) Aminoindazole derivatives and use thereof as kinase inhibitors
IL179030A0 (en) Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
UA86809C2 (en) Piperazine derivatives of alkyl oxindoles
UA86978C2 (en) Piperazine derivatives of dialkyl oxindoles